KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Inventory Average (2019 - 2025)

Castle Biosciences (CSTL) has disclosed Inventory Average for 7 consecutive years, with $9.5 million as the latest value for Q4 2025.

  • Quarterly Inventory Average rose 28.54% to $9.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.5 million through Dec 2025, up 28.54% year-over-year, with the annual reading at $9.2 million for FY2025, 14.38% up from the prior year.
  • Inventory Average hit $9.5 million in Q4 2025 for Castle Biosciences, up from $8.5 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $9.5 million in Q4 2025 to a low of $2.2 million in Q1 2022.
  • Historically, Inventory Average has averaged $5.4 million across 5 years, with a median of $5.6 million in 2023.
  • Biggest five-year swings in Inventory Average: soared 94.46% in 2023 and later dropped 3.87% in 2025.
  • Year by year, Inventory Average stood at $2.2 million in 2021, then soared by 77.02% to $3.9 million in 2022, then soared by 76.19% to $6.9 million in 2023, then increased by 7.26% to $7.4 million in 2024, then grew by 28.54% to $9.5 million in 2025.
  • Business Quant data shows Inventory Average for CSTL at $9.5 million in Q4 2025, $8.5 million in Q3 2025, and $7.6 million in Q2 2025.